Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. As an immune suppressor it is used in nephrotic syndrome…
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Cyclophosphamide.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Cyclophosphamide shows recurring relationship patterns in the source. For example, Cyclophosphamide → As, ASTA, Baxter Oncology, Brock, Colvin, FDA, In, Norbert Brock, Once, The, They, This Another extracted example is Cyclophosphamide → AML, CMF-therapy, For, Hodgkin, Myeloproliferative, Other, Secondary, The, This. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
used cancer effects bladder mustard cell leukemia treatment side may drug dose use include acrolein infertility chemotherapy active metabolites cells
TTTA extracted 113 structured relationships around Cyclophosphamide. Examples in this analysis include Cyclophosphamide → 3D model (JSmol) → Interactive image and Cyclophosphamide → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Cyclophosphamide | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Cyclophosphamide | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Cyclophosphamide | ATC code | L01AA01 (WHO) | 1.00 | infobox |
| Cyclophosphamide | Bioavailability | >75% (by mouth) | 1.00 | infobox |
| Cyclophosphamide | CAS Number | 50-18-0 Y | 1.00 | infobox |
| Cyclophosphamide | ChEBI | CHEBI:4027 Y | 1.00 | infobox |
| Cyclophosphamide | ChEMBL | ChEMBL88 Y | 1.00 | infobox |
| Cyclophosphamide | ChemSpider | 2804 Y | 1.00 | infobox |
| Cyclophosphamide | CompTox Dashboard (EPA) | DTXSID5020364 | 1.00 | infobox |
| Cyclophosphamide | DrugBank | DB00531 Y | 1.00 | infobox |
| Cyclophosphamide | ECHA InfoCard | 100.000.015 | 1.00 | infobox |
| Cyclophosphamide | Elimination half-life | 3–12 hours | 1.00 | infobox |
| Cyclophosphamide | Excretion | Kidney | 1.00 | infobox |
| Cyclophosphamide | Formula | C7H15Cl2N2O2P | 1.00 | infobox |
| Cyclophosphamide | KEGG | D07760 Y | 1.00 | infobox |
| Cyclophosphamide | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Cyclophosphamide | Legal status | CA: ℞-only | 1.00 | infobox |
| Cyclophosphamide | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Cyclophosphamide | Legal status | US: ℞-only | 1.00 | infobox |
| Cyclophosphamide | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Cyclophosphamide | MedlinePlus | a682080 | 1.00 | infobox |
| Cyclophosphamide | Melting point | 2 °C (36 °F) | 1.00 | infobox |
| Cyclophosphamide | Metabolism | Liver | 1.00 | infobox |
| Cyclophosphamide | Molar mass | 261.08 g·mol−1 | 1.00 | infobox |
| Cyclophosphamide | Pregnancy category | AU: D | 1.00 | infobox |
| Cyclophosphamide | Pronunciation | /ˌsaɪkloʊˈfɒsfəˌmaɪd, -lə-/ | 1.00 | infobox |
| Cyclophosphamide | Protein binding | >60% | 1.00 | infobox |
| Cyclophosphamide | PubChem CID | 2907 | 1.00 | infobox |
| Cyclophosphamide | Routes of administration | By mouth, by injection into a vein | 1.00 | infobox |
| Cyclophosphamide | Trade names | Lyophilized Cytoxan, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cycloblastin | 1.00 | infobox |
The concept neighborhoods around Cyclophosphamide bring nearby vocabulary together. In this analysis, examples include Drug, Used and Use. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Cyclophosphamide, one of the stronger structural bridges in this analysis connects Cyclophosphamide with Medical uses. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Cyclophosphamide to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Cyclophosphamide · EN edition · Analysis: TopicsToTalkAbout